Insider filing · TARS
Dianne C. Whitfield
Chief Human Resources Officer
profile →
Tarsus Pharmaceuticals, Inc.
TARS · Healthcare · 35 filings in 24 months
ticker →
Dianne C. Whitfield sold $321K of Tarsus Pharmaceuticals (TARS)
Executed Mar 18 2025, disclosed Mar 20 2025, 2 days later.
Value, as filed
$321K
6,711 sh across 3 lots
Executed
Mar 18 2025
the trade date, as filed
Disclosed
Mar 20 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DWDianne C. Whitfield (Chief Human Resources Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $1.1M of TARS (13,837 sh across 2 lots, as filed), executed Jan 2.
The name
TARSHealthcare · Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Dianne C. Whitfield in TARS
TARSSALE
Tarsus Pharmaceuticals, Inc.
$839K12,274 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $1.1M
13,837 sh across 2 lots
Exec Jan 2
Filed Jan 6 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $592K
7,397 sh × $80.10
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET